Bioniche Life Scienc (BNHLF) 0.2970 $BNHLF Telesta

New Post Public Reply Private Reply Replies (0) Message Board

May 17, 2015 at 1:48 PM

Bioniche Life Scienc (BNHLF) 0.2970 $BNHLF

Telesta Therapeutics Publishes its Nine Month Financial Results to March 31, 2015 and Provides Corporate Updates
PR Newswire - Thu May 14, 4:34PM CDT
Telesta Therapeutics Inc. (TSX:TST; PNK:BNHLF) today issued its financial statements and associated Management's Discussion and Analysis (MD&A), for the nine month period ended March 31, 2015 which are now published in full on SEDAR at www.sedar.com and on the Company's website at www.telestatherapeutics.com. In addition Telesta provided key corporate updates:
TST.TO: 0.35 (unch)

Telesta Therapeutics Provides Key Corporate Updates
CNW Group - Mon Apr 27, 7:50AM CDT
Telesta Therapeutics Inc. (TSX:TST; PNK:BNHLF) provided the following key corporate updates:
TST.TO: 0.35 (unch)

IIROC Trade Resumption - TST
CNW Group - Fri Feb 13, 9:08AM CST
Trading resumes in:
TST.TO: 0.35 (unch)

IIROC Trade Resumption - Telesta Therapeutics Inc.
Newsfile Corp - Fri Feb 13, 9:06AM CST
Trading resumes in:

Telesta Therapeutics Publishes its 6 Month Financial Results to December 31, 2014 and Provides Important Corporate Updates
CNW Group - Fri Feb 13, 8:53AM CST
Telesta Therapeutics Inc. (TSX:TST; PNK:BNHLF) today issued its financial statements and associated Management's Discussion and Analysis (MD&A), for the 6 month period ended December 31, 2014. In addition Telesta provided key corporate updates covering:
TST.TO: 0.35 (unch)

IIROC Trading Halt - TST
CNW Group - Fri Feb 13, 8:29AM CST
The following issues have been halted by IIROC:
TST.TO: 0.35 (unch)

IIROC Trade Halt - Telesta Therapeutics Inc.
Newsfile Corp - Fri Feb 13, 8:28AM CST
The following issues have been halted by IIROC:

Telesta Therapeutics Announces Key Clinical & Corporate Updates
PR Newswire - Mon Dec 01, 8:29AM CST
Telesta Therapeutics Inc. (TSX: TST; PNK: BNHLF) (Formerly Bioniche Life Sciences Inc. TST:BNC) today affirmed that they remain on track with their internal objective of filing a Biologics License Application (BLA) for marketing approval with the US Food and Drug Administration (FDA) for MCNA 1 prior to March 31, 2015. Two recent key accomplishments include the completion of both a pre-BLA meeting with the US FDA and a mock-audit of Telesta's MCNA manufacturing facility. As the result of the pre-BLA meeting, Telesta received written answers and verbal feedback to a number of clinical, manufacturing and regulatory items related to the filing of their BLA while the manufacturing "mock-audit" saw a third party firm complete a detailed and exhaustive review intended to simulate the type of audit that Telesta is expected to be subject to, by the FDA, during the course of a BLA review process.
TST.TO: 0.35 (unch)

Bioniche Life Sciences Inc. Rebrands as Telesta Therapeutics Inc.
PR Newswire - Mon Nov 24, 8:00AM CST
Bioniche Life Sciences Inc. (TSX: BNC PNK: BNHLF) Bioniche Life Sciences today announced the accomplishment of another major milestone in the execution of its strategic plan to become a focused late stage human therapeutics company with near term commercial potential. Effective immediately, the Company will begin operating under its new corporate name and identity, Telesta Therapeutics Inc.
BNC.TO: 0.21 (unch)

Bioniche Life Sciences Inc. announces results of annual general meeting of shareholders
PR Newswire - Thu Nov 13, 10:10AM CST
Bioniche Life Sciences Inc. (TSX: BNC) ("Bioniche" or the "Company"

is pleased to provide the results from its annual general meeting of shareholders held November 12, 2014 in Toronto (the "Meeting"

.
BNC.TO: 0.21 (unch)

Bioniche Life Sciences Inc. Reports MCNA Update & First Quarter Results
PR Newswire - Wed Nov 12, 6:55AM CST
(all figures are in Canadian dollars unless otherwise noted)
BNC.TO: 0.21 (unch)

Orphan Drug Designation Update and Annual General Meeting Reminder
PR Newswire - Wed Nov 05, 3:35PM CST
Bioniche Life Sciences Inc. (TSX: BNC) today announced that it will not continue its dialogue with the US Food & Drug Administration (FDA) concerning its request for Orphan Drug Designation (ODD) for its bladder cancer therapeutic, Mycobacterium phlei cell-wall - nucleic acid complex (MCNA). The FDA has indicated that it could not grant Bioniche's request for ODD at this time, because the Company had not established to its satisfaction that the target population estimate for MCNA did not exceed 200,000 potential patients in the US.
BNC.TO: 0.21 (unch)

Bioniche Life Sciences Inc. to Publish Comprehensive Phase 3 Clinical Trial Results In The Journal of Urology
PR Newswire - Fri Oct 10, 7:00AM CDT
Bioniche Life Sciences Inc. (TSX: BNC: PNK:BNHLF) today announced that The Journal of Urology has accepted for publication a manuscript entitled: Efficacy and Safety of MCNA in Patients with Non-Muscle Invasive Bladder Cancer at High-Risk of Recurrence and Progression Who Have Failed Treatment with BacillusCalmette-Guérin. An unedited version of the paper is now available for review and citation online at www.jurology.com (http://www.jurology.com/article/S0022-5347(14)04590-X/abstract); with an expected in print date tentatively scheduled for April 2015.
BNC.TO: 0.21 (unch)

Veterinary Purchasing Company Limited Appoints a New CEO
CNW Group - Wed Oct 01, 8:00AM CDT
The Board of Directors of Veterinary Purchasing Company Limited (VPCL) today announced the appointment of a new Chief Executive Officer. Mr. Rick Culbert takes over the role from Mr. Brendan Ginty, who is retiring after 39 years of leadership.

Bioniche Life Sciences Inc. Reports Fiscal 2014 Year-End Results
PR Newswire - Fri Sep 26, 4:12PM CDT
(all figures are in Canadian dollars unless otherwise noted)
BNC.TO: 0.21 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mount St. Mary's University Climbs in College Rankings

Moving Up the Rankings Ladder Mount St. Mary's University has been making waves not only on campus but in the highly competitive world of college rankings. The institution has managed to climb the ranks in the 2026–27 U.S. News & World Report Best Colleges rankings, a feat that's not just some idle happenstance. The Numbers Speak If you've been paying attention, the...

Koppers Faces Investigation: Investors Cautious Amid Probe

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Tenax Sued: Investors Face Class Action Over TNX-103

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

Pepsi Drivers in Georgia Gear Up for a Strike Showdown

Teamsters Turn Up the Heat in Georgia Well, folks, buckle up because we've got ourselves a brewing labor storm down in Georgia! Over 100 Pepsi-Cola drivers, holding the steering wheel firm under Teamsters Local 528, are about ready to slam their fists down and go on strike. They've had it up to here with management's tap-dancing around negotiations. Drivers Say Enough Is...

Preventing Dental Issues in Kids: Valuable Tips Shared

Pediatric Dental Challenges Under the Microscope When it comes to kids and dental health, we're talking about the fundamentals—the kind that sticks around and makes a difference in their future pearly whites. None of that flashy tech gizmo stuff, just straight-on strategies for resilient chompers. Cavities, gum irritation, early tooth alignment—these are the everyday...

An Extra Helping of Community Spirit Rutter Mills is back on the scene again this Thanksgiving, slinging out a thousand turkeys to show their appreciation for the community they’ve called home since 1959. This initiative is the second iteration of their Turkey Drop, an event that's set to become a cherished tradition for years to come. Last year's event only teased the...

Yiren Digital's Tumble: Lawsuit Timeline for Investors

Yiren's Stock Plunge and the Legal Quagmire What a mess Yiren Digital Ltd. (NYSE:YRD) finds itself in, huh? We're looking at a stunning 44.05% stock nosedive that's left a trail of bruised investors in its wake. Now that's a real gut-punch for any portfolio hugging YRD. So, what's spinning this cycle of chaos for our digital player from across the pond? The Flash Point:...

JOYEE N01 Kicks Off Global Launch with African Orders

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

TEN Holdings' Q3: Cost Cuts Fuel Revenue Ambitions

TEN Holdings Eyes the Future While Cleaning House If there’s one thing that catches the eye about TEN Holdings' Q3 2026 results, it’s the laser-focused cleanup of their balance sheet. They’ve slashed liabilities by 74%, up from $7.7 million at the arse end of last year to just over $2 million now. They did that by making some hard moves, hacking away at operating...

Key Players Depart No Makeup Makeup Amid Rapid Success

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...